Nitric oxide metabolite levels in acute vaso-occlusive sickle-cell crisis

Academic Emergency Medicine

Volumn 3, Issue 12, 1996, Pages 1098-1102

  Lopez, Bernard L ^a,b   Barnett, Jordan ^a   Ballas, Samir K ^a   Christopher, Theodore A ^a   Davis Moon, Linda ^a   Ma, Xin Liang ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

emergency department; nitric oxide; NO; sickle cell anemia, vaso occlusive crisis; sickle cell painful crisis

Indexed keywords

NITRATE; NITRIC OXIDE; NITRITE;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD VESSEL OCCLUSION; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; ISCHEMIA; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SICKLE CELL ANEMIA; SICKLE CELL CRISIS;

EID: 0029853004     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.1996.tb03367.x     Document Type: Article

References (34)

1. Bolsen B. Advances continue in sickle-cell disease. JAMA. 1982; 247:1540-5.
2. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980; 288:373-6.
3. Rappaport JM, Bunn HF. Bone marrow failure: aplastic anemia and other primary bone marrow disorders. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al. (eds). Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1994, pp 1754-6.
4. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci. 1987; 84: 9265-9.
5. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987; 2:1057-8.
6. Rubanyi GM, Vanhoute PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 1986; 250: H822-H827.
7. Sun JZ, Kaur H, Halliwell B, Li XY, Bolli R. Use of aromatic hydroxylation of phenylalanine to measure production of hydroxyl radicals after myocardial ischemia in vivo. Circ Res. 1993; 73:534-49.
8. Yue TL, McKenna PJ, Gu JL, Cheng HY, Ruffolo RR, Feuerstein GZ. Carvedilol, a new antihypertensive agent, prevents Iipid peroxidation and oxidative injury to endothelial cells. Hypertension. 1993; 22: 922-8.
9. Moncada S, Palmer RMJ, Gryglewski RJ. Mechanism of action of some inhibitors of endothelium-derived relaxing factor. Proc Natl Acad Sci USA. 1986; 83: 9164-8.
10. Hibbs JB Jr., Vavrin Z, Taintor RR, Raichlin EM. Nitric oxide: a cytotoxic-activated macrophage effector molecule. Biochem Biophys Res Commun. 1988; 157:87-94.
11. 2+ concentrations in the production of endothelial nitric oxide and the control of vascular tone. Br J Pharmacol. 1990; 101:489-93.
12. Chin JH, Azhar S, Huffman BB. Inactivation of endothelium-derived relaxing factor by oxidized lipoproteins. J Clin Invest. 1992; 89: 10-8.
13. Rees DC, Satsangi J, Cornelissen PL, Travis SP, White J, Jewell DP. Are concentrations of nitric oxide metabolites useful in predicting the clinical outcome of severe ulcerative colitis? Eur J Gastroenterol Hepatol. 1995; 7:227-30.
14. Winlaw DS, Smythe GA, Keough AM, Schyvens CS, Spratt PM, MacDonald PS. Increased nitric oxide production in heart failure. Lancet. 1994; 344:373-4.
15. Neilly IJ, Copland M, Haj M, Adey G, Benjamin N, Bennett B. Plasma nitrate concentrations in neutropenic and non-neutropenic patients with suspected septicaemia. Br J Haematol. 1995; 89:199-202.
16. Barthlen W, Stadler J, Lehn NL, Miethke T, Bartels H, Siewert JR. Serum levels of end products of nitric oxide synthesis correlate positively with tumor necrosis factor alpha and negatively with body temperature in patients with abdominal sepsis. Shock. 1994; 6:398-401.
17. Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with sepsis syndrome. Circ Shock. 1993; 41:77-81.
18. Rees DC, Cervi P, Grimwade D, et al. The metabolites of nitric oxide in sickle-cell disease. Br J Haematol. 1995; 91:834-7.
19. Zeballos GA, Bernstein RD, Thompson CI, et al. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation. 1995; 91:2982-8.
20. Braman RS, Hendrix SA. Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection. Anal Chem. 1989; 61: 2715-8.
21. Bush PA, Gonzalez NE, Griscavage JM, Ignarro LJ. Nitric oxide synthase from cerebellum catalyzes equimolar quantities of nitric oxide and citrulline from L-arginine. Biochem Biophys Res Commun. 1992; 185:960-6.
22. Marceira-Rodriquez L, Gernsheimer J, Osborn HH. Emergency management of sickle-cell anemia. Hosp Physician. 1985; Mar:14-29.
23. Konotey-Ahulu FID. The sickle-cell diseases: clinical manifestations including the "sickle crisis." Arch Intern Med. 1974; 133:611-9.
24. Randall MD, Griffith TM. EDRF plays a central role in collateral flow after arterial occlusion in rabbit ear. Am J Physiol (Heart Circ Physiol). 1992; 263:H752-H760.
25. Yamabe H, Okumura K, Ishizaka H, Tsuchiya T, Yasue H. Role of endothelium-derived nitric oxide in myocardial reactive hyperemia. Am J Physiol (Heart Circ Physiol). 1992; 263:H8-H14.
26. Selwyn AP, Braunwald E. Ischemic heart disease. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al. (eds). Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1994, pp 1077-8.
27. Green LC, Ruiz de Luzuriaga K, Wagner DA. Nitrite biosynthesis in man. Proc Natl Acad Sci U S A. 1981; 78:7764-8.
28. Johnson G, Tsao PS, Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med. 1991; 19:244-52.
29. Del Zoppo GJ. Microvascular changes during cerebral ischemia and reperfusion. Cerebrovasc Brain Metab Rev. 1994; 6:47-96.
30. Hutcheson IR, Whittle BJR, Boughton-Smith NK. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage. Br J Pharmacol. 1990; 101:815-20.
31. Kawabata A, Manabe S, Manabe Y, Takagi H. Effect of topical administration of 1-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br J Pharmacol. 1994; 112:547-50.
32. Holthusen H, Arndt JO. Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci Lett. 1994; 165:71-4.
33. Lucas GS, Caldwell NM, Stuart J. Fluctuating deformity of oxygenated sickle erythrocytes in the asymptomatic state and in painful crisis. Br J Haematol. 1985; 59:992-5.
34. Bockman OC, Dahl R, Bjerkland-Johansen TE, Strand O, Tacker CO, Granli T. Normal and abnormal rates of nitrate excretion in humans [abstract]. Endothelium. 1995; 3:s16.